Advances in psychiatry and nuerology


ISSN 1234-8279

ISSN on-line 2449-9315 

 

MNiSW: 20

Index Copernicus 2023: 90.54

Editorial panel
Submitting and reviewing works online
  • Home page
  • >
  • Archive
  • >
  • issue 4
  • >
  • Wstępne wyniki stosowania dużych dawek piracetamu podawanych dożylnie u pacjentów z zespołem otępiennym

Archive 1995–2023

1995, volume 11, issue 4
Article

Wstępne wyniki stosowania dużych dawek piracetamu podawanych dożylnie u pacjentów z zespołem otępiennym

Farmakoterapia w Psychiatrii i Neurologii, 1995, 4, 77-82
Summary

In this paper preliminary, results of high doses intravenous Piracetam in the treatment of dementia and actigraphic monitoring are discussed. During course of i.v. Piracetam (12 g daily) and following period of 4.8 g Piracetam p.o. no side effects were observed. Patients showed improvement in c1inical scales (Information-Memory-Concentration Test, Mini-Mental State Examination). Actigraphic results showed increased motor activity after treatment, equally distributed for both day and night.

You have added an item to your cart
Restore password
Shopping cart (0)
No products in your cart
Font size
Contrast
Underlined links